Page 1

Sensus Healthcare TECHNOLOGY THAT CARES Exhibit 99.1 Sensus Healthcare Reports Third Quarter 2021 Financial Results Achieves profitability on revenues of $ 5.5 million , up sharply from $ 1.6 million a year ago Affirms expectations for continued growth in 4Q and full - year profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON , Fla . ( November 4 , 2021 ) – Sensus Healthcare , Inc. ( Nasdaq : SRTS ) , a medical device company specializing in highly effective , non- invasive , minimally - invasive and cost - effective treatments for oncological and non - oncological conditions , announces financial results for the three and nine months ended September 30 , 2021 . Highlights from the third quarter of 2021 and recent weeks include the following ( all comparisons are with the third quarter of 2020 , unless otherwise indicated ) : • Revenues were $ 5.5 million , up 244 % • Net income was $ 0.2 million , or $ 0.01 per diluted share , compared with a net loss of $ ( 1.7 ) million , or $ ( 0.10 ) per share • Adjusted EBITDA , a non - GAAP financial measure , was a positive $ 0.5 million , compared with a negative $ ( 1.5 ) million • Shipped 14 systems including eight SRT - 100 Vision systems , and one SRT - 100 system shipped to China • Affirms expectations for fourth quarter and full year 2021 profitability • Received a five - year license renewal for the SRT - 100 ™ from the Chinese Health Authority Management Commentary “ The third quarter and subsequent weeks featured several encouraging events that bode well for continued sales growth , not only in the fourth quarter but through 2022 , " said Joe Sardano , chairman and chief executive officer of Sensus Healthcare . " We reported our first profitable third quarter in our company's history , and based on a robust backlog of orders we believe Sensus will report positive net income for 2021 . " Our domestic business is significantly improved compared with the pandemic - impacted third quarter of 2020 , with 14 systems shipped including eight premium SRT - 100 Vision ™ systems . We are highly encouraged by the reception our new fair - market - leasing program has received to date . Our physician customers are beginning to take advantage of this offering and its ability to provide a positive ROI for the SRT - 100 Vision by treating just two patients per month . In addition , our organization has done an excellent job in articulating the improved CMS reimbursement rates that went into effect at the start of the year , along with the benefits of SRT to a growing number of physicians . This has led to improved patient volumes at customer sites , as well . " Our SRT systems were well received at last month's Fall Clinical held live in Las Vegas and virtually . This conference provided the opportunity for us to demonstrate our technology in person for the first time in more than 18 months , and interest in our products and the number of new sales leads both were strong . In addition , conference presentations on the safety and efficacy of SRT , and discussions of improved reimbursement by key opinion leaders supported our presence . "